Prognosis of Bronchiectasis in Children--A Multicenter Prospective Cohort Study
NCT ID: NCT02564731
Last Updated: 2017-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2016-06-30
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Aetiology of Children With Bronchiectasis in China
NCT02555865
Registry Study on Respiratory Monogenic Diseases in Chinese Children
NCT03528525
Multicenter Cohort Study on Predicting Bronchiectasis Progression, Complications, and Prognosis Using Multi-omics
NCT07263373
Clinimetric Properties of Outcome Measures in Bronchiectasis in the UK
NCT02468271
Exhaled Breath Condensate Assessment in Stable Non-Cystic Fibrotic Bronchiectasis
NCT03643263
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* lack of bronchial tapering
* bronchi visible in the peripheral 1cm of lung
* bronchial diameter greater than adjacent segmental bronchi
Exclusion Criteria
* undergoing trial for other medications or instruments.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wuhan women and children's health care center
UNKNOWN
Children's Hospital of Chongqing Medical University
OTHER
Yuying Children's Hospital of Wenzhou Medical University
OTHER
Changchun Children's Hospital
OTHER
Shenzhen Children's Hospital
OTHER_GOV
Jiangxi Province Children's Hospital
OTHER
Shanghai Children's Medical Center
OTHER
First Affiliated Hospital of Guangxi Medical University
OTHER
Tianjin Children's Hospital
OTHER
The First Affiliated Hospital of Xiamen University
OTHER
Children's Hospital of Fudan University
OTHER
The Affiliated Hospital Of Guizhou Medical University
OTHER
Shanxi Provincial Maternity and Children's Hospital
OTHER
Baoping XU
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Baoping XU
Chief of Respiratory Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kunling Shen, MD,PhD
Role: STUDY_DIRECTOR
Beijing Children's Hospital of Capital Medical University, China
Baoping Xu, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Beijing Children's Hospital of Capital Medical University, China
Xiaoxia Peng, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Beijing Children's Hospital of Capital Medical University, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Children'S Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
baoping xu
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Karakoc GB, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis: still a problem. Pediatr Pulmonol. 2001 Aug;32(2):175-8. doi: 10.1002/ppul.1104.
Munro KA, Reed PW, Joyce H, Perry D, Twiss J, Byrnes CA, Edwards EA. Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression? Pediatr Pulmonol. 2011 Feb;46(2):131-8. doi: 10.1002/ppul.21331. Epub 2010 Aug 17.
Twiss J, Stewart AW, Byrnes CA. Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis. Thorax. 2006 May;61(5):414-8. doi: 10.1136/thx.2005.047332. Epub 2006 Feb 7.
Murray MP, Pentland JL, Hill AT. A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009 Nov;34(5):1086-92. doi: 10.1183/09031936.00055509. Epub 2009 Jun 18.
Davies G, Wilson R. Prophylactic antibiotic treatment of bronchiectasis with azithromycin. Thorax. 2004 Jun;59(6):540-1. No abstract available.
Valery PC, Morris PS, Byrnes CA, Grimwood K, Torzillo PJ, Bauert PA, Masters IB, Diaz A, McCallum GB, Mobberley C, Tjhung I, Hare KM, Ware RS, Chang AB. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med. 2013 Oct;1(8):610-620. doi: 10.1016/S2213-2600(13)70185-1. Epub 2013 Sep 17.
Gaylor AS, Reilly JC. Therapy with macrolides in patients with cystic fibrosis. Pharmacotherapy. 2002 Feb;22(2):227-39. doi: 10.1592/phco.22.3.227.33544.
WANG Hao，XU Bao-ping，LIU Xiu-yun，HU Ying-hui，REN Yi-xin，SHEN Kun-ling. Clinical characteristics and follow-up of bronchiectasis in children. Chinese Journal of Practical Pediatrics, 2014;29 (12):936-939
CHEN Jun, DUO Li-kun, WANG Xiao-feng. Clinical analysis of 22 children with bronchiectasis. J Clin Pediatr, 2012, 30(1):51-54.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BCHlung003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.